| Arthur Wang, OD | |
|
1083 Cedar Ave, Marysville, WA 98270-4232 | |
| (360) 659-1446 | |
| Not Available |
| Full Name | Arthur Wang |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 12 Years |
| Location | 1083 Cedar Ave, Marysville, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558617126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD60285509 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Doctors Of Marysville Inc | 1153559190 | 2 |
News Archive
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Dr. Michael Grey, who leads a project to monitor ex-footballers for early signs of dementia, has welcomed new guidelines that ban children from heading footballs during training.
The National Heart Foundation of Australia has launched a new campaign aimed at tackling overweight and obesity in children.
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the Federal Trade Commission (FTC) has accepted a proposed consent order for public comment relating to Watson's pending acquisition of privately held Arrow Group and has granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.
› Verified 9 days ago
| Provider Name | Eye Doctors Of Marysville Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275961310 PECOS PAC ID: 1153559190 Enrollment ID: O20140120000648 |
News Archive
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Dr. Michael Grey, who leads a project to monitor ex-footballers for early signs of dementia, has welcomed new guidelines that ban children from heading footballs during training.
The National Heart Foundation of Australia has launched a new campaign aimed at tackling overweight and obesity in children.
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the Federal Trade Commission (FTC) has accepted a proposed consent order for public comment relating to Watson's pending acquisition of privately held Arrow Group and has granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arthur Wang, OD 19708 15th Ave Ne, Apt 29, Shoreline, WA 98155-1189 Ph: (314) 749-2311 | Arthur Wang, OD 1083 Cedar Ave, Marysville, WA 98270-4232 Ph: (360) 659-1446 |
News Archive
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Dr. Michael Grey, who leads a project to monitor ex-footballers for early signs of dementia, has welcomed new guidelines that ban children from heading footballs during training.
The National Heart Foundation of Australia has launched a new campaign aimed at tackling overweight and obesity in children.
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the Federal Trade Commission (FTC) has accepted a proposed consent order for public comment relating to Watson's pending acquisition of privately held Arrow Group and has granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.
› Verified 9 days ago
Dr. Kristin A. Colonna, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2335 172nd St Ne, Marysville, WA 98271 Phone: 360-651-1550 | |
Dr. Jennifer Marie Christman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 | |
Cody Good, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 | |
Marysville Vision Source Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 Fax: 360-653-2466 | |
Dr. Emily Camchau Do Nguyen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16616 Twin Lakes, Marysville, WA 98271 Phone: 360-652-4543 Fax: 360-652-4544 | |
Daniel Samaniego, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1262 State Ave, Marysville, WA 98270 Phone: 360-651-7450 | |
Eye Doctors Ltd Ps Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1083 Cedar Ave, Marysville, WA 98270 Phone: 360-659-1446 Fax: 360-659-7324 |